These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6358617)

  • 1. [Mealtime insulin secretion and maturity-onset diabetes].
    Assan R
    Journ Annu Diabetol Hotel Dieu; 1983; ():273-4. PubMed ID: 6358617
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin secretion and action and diabetes mellitus.
    Goldfine ID; Pilch P
    J Cell Biochem; 1992 Jan; 48(1):1-2. PubMed ID: 1583071
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin secretion: movement at all levels.
    Henquin JC; Boitard C; Efendic S; Ferrannini E; Steiner DF; Cerasi E
    Diabetes; 2002 Feb; 51 Suppl 1():S1-2. PubMed ID: 11815449
    [No Abstract]   [Full Text] [Related]  

  • 4. [From obesity to diabetes or the natural history of abnormalities in the secretion and action of insulin].
    Scheen AJ
    Rev Med Liege; 1992 Jul; 47(7):325-37. PubMed ID: 1636074
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes, insulin secretion, and the pancreatic beta-cell mitochondrion.
    Langin D
    N Engl J Med; 2001 Dec; 345(24):1772-4. PubMed ID: 11742055
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic B-cell dysfunction and glucose toxicity in non-insulin-dependent diabetes.
    Flatt PR; Abdel-Wahab YH; Boyd AC; Barnett CR; O'Harte FP
    Proc Nutr Soc; 1997 Mar; 56(1B):243-62. PubMed ID: 9168536
    [No Abstract]   [Full Text] [Related]  

  • 7. The islet in type 2 diabetes: back to center stage.
    Cerasi E; Boitard C; Efendic S; Ferrannini E; Henquin JC; Steiner DF
    Diabetes; 2001 Feb; 50 Suppl 1():S1-3. PubMed ID: 11272163
    [No Abstract]   [Full Text] [Related]  

  • 8. Interrelationships between body weight, insulin secretion from B cell and metabolic control in type 2 (non-insulin-dependent) diabetics with fasting hyperglycemia.
    Pasquali R; Buratti P; Biso P; Mattioli L; Capelli M; Melchionda N; Labò G
    Panminerva Med; 1987; 29(3):181-8. PubMed ID: 3320883
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical bases of abnormalities of glucose metabolism in non-insulin-dependent diabetes].
    Girard J
    Journ Annu Diabetol Hotel Dieu; 1993; ():81-96. PubMed ID: 8392644
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of pancreatic beta-cells in type I and II diabetes: clinical implications?].
    Waeber G
    Rev Med Suisse Romande; 1995 Sep; 115(9):627-34. PubMed ID: 7481346
    [No Abstract]   [Full Text] [Related]  

  • 11. Arachidonic acid metabolite regulation of insulin secretion.
    Robertson RP
    Diabetes Metab Rev; 1986; 2(3-4):261-96. PubMed ID: 3091336
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dysfunction of the pancreatic beta cells observed in non-insulin-dependent diabetes].
    Waeber G
    Rev Med Suisse Romande; 1993 Sep; 113(9):695-8. PubMed ID: 8210896
    [No Abstract]   [Full Text] [Related]  

  • 13. [The significance of leptin for the pathogenesis of diabetes mellitus type 2. Direct effects on endocrine pancreas].
    Seufert J
    Internist (Berl); 1999 Aug; 40(8):894-7. PubMed ID: 10532844
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypothalamic AMP-activated Kinase Regulates Glucose-stimulated Insulin Secretion.
    Koh EH; Lee KU
    EBioMedicine; 2016 Nov; 13():11-12. PubMed ID: 27815099
    [No Abstract]   [Full Text] [Related]  

  • 15. Predicting type II diabetes in persons at risk.
    Osei K
    Ann Intern Med; 1990 Dec; 113(12):905-7. PubMed ID: 2240913
    [No Abstract]   [Full Text] [Related]  

  • 16. Nitrite increases glucose-stimulated insulin secretion and islet insulin content in obese type 2 diabetic male rats.
    Gheibi S; Bakhtiarzadeh F; Jeddi S; Farrokhfall K; Zardooz H; Ghasemi A
    Nitric Oxide; 2017 Apr; 64():39-51. PubMed ID: 28089828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulation of ATP-dependent potassium channels].
    De Weille JR; Schmid-Antomarchi H; Fosset M; Lazdunski M
    Journ Annu Diabetol Hotel Dieu; 1991; ():119-24. PubMed ID: 1715929
    [No Abstract]   [Full Text] [Related]  

  • 19. [Why is insulin release from beta cells insufficient in type 2 diabetes?].
    Grill V
    Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2796-8. PubMed ID: 11107928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 stimulates insulin secretion by a Ca2+-independent mechanism in Zucker diabetic fatty rat islets of Langerhans.
    Sreenan SK; Mittal AA; Dralyuk F; Pugh WL; Polonsky KS; Roe MW
    Metabolism; 2000 Dec; 49(12):1579-87. PubMed ID: 11145120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.